Important studies being presented at the Symptom Science Poster Session ASCO w/ great takeaways and action steps!
🫀 Consider cardiac eval for breast arterial calcifications
💤 Consider sleep study for cognitive impairment
🩸Monitor glucose and think about acupuncture! #asco24

Please join me for the Dempsey Center In Good Taste Gala Thurs, June 20 at The Landing at Pine Point in Scarborough, Maine, with Patrick Dempsey Tom Caron + friends, some great food, and supporting people impacted by cancer
Purchase tickets today ➡️ support.dempseycenter.org/index.cfm?fuse…

I’m excited to support G Curigliano MD PhD for the ESMO Presidential Elections!

A compassionate clinician and true leader in drug development, Giuseppe has trained an entire generation of young physicians, with a transformative impact in oncology.

Make sure to vote for him from May 28!

So excited to see these abstracts, which are really just the tip of the iceberg at #ASCO24
Every year the commitment and passion to advancing the care of patients with cancer is so empowering & energizing for me professionally—can’t wait to see & hear it all. OncoAlert ASCO

Way to go Nancy Lin, MD!! 🥂🎉🙌🏻

Amazing team we have here! Stephanie Graff, MD, FACP, FASCO Sendurai Mani Robert W. Sobol Caris Life Sciences

One week away and let me tell y'all - I have *earned* a little shopping Max Mara, down time with friends, and networking all to support Conquer Cancer, the ASCO Foundation. I hope to see you there. #ASCO24 Lori Pierce Rachna Shroff, MD, FASCO

#TDRG #TDRG retreat
Excited for TDRG retreat that just started here at Legorreta Cancer Center at Brown University !

#ASCO24 ProTip— Be this moderator ⬇️⬇️⬇️

Also—introduce all speakers correctly & formally. Ask for title & pronunciation. Practice. YOU CAN DO IT! See: ascopubs.org/doi/abs/10.120… 🙌🏻

ESMO Presidential Election: 2027-2028
I am supporting ⁦G Curigliano MD PhD⁩ for his vision to lead ⁦ESMO - Eur. Oncology⁩ as the global organisation promoting cancer care and innovation worldwide ⁦OncoAlert⁩ ⁦EORTC Breast Cancer Group⁩ esmo.org/about-esmo/how…

Just another reason to move to #RhodeIsland and come work with me, Wafik S. El-Deiry, MD, PhD, FACP, Sendurai Mani, Robert W. Sobol and more. THIS is my view every morning :
Legorreta Cancer Center at Brown University #WaterViews

🙌Excited to join these amazing researchers & advocates posting #ASCO24 #SoMe insights ASCO

Charbel Matar @twooncdocs Darcy Burbage, DNP, RN, AOCN Jacob J. Adashek, DO Shearwood McClelland III, M.D. Martina Murphy, MD Rafeh Naqash, MD Allison Rosen, MS Ramy Sedhom, MD @AshleysumrallMD Kekoa Taparra, MD, PhD Eleonora Teplinsky, MD Yüksel Ürün Shannon Westin, MD, MPH, FASCO

Who wants to shop w/ me and for a great cause?? #ASCO24 is almost here which means it’s time to support Conquer Cancer, the ASCO Foundation - see you Friday 5/31 from 4-6pm and have a glass of bubbly with us while you shop Max Mara! Or shop anytime during the weekend! ASCO Lori Pierce Stephanie Graff, MD, FACP, FASCO

If you love writing, medical humanities, art of oncology in Journal of Clinical Oncology JCO Global Oncology and JCO Oncology Practice, or just want to hang out with the cool kids 😎—I hope you’ll come by for our #ASCO24 session! 📝👩🏼‍💻📑

I thought ⁦ESMO - Eur. Oncology⁩ scheduling #ESMOBreast24 days before #ASCO24 was hard on breast oncologists, now this!?!

🥂Huge congratulations ⁦G Curigliano MD PhD⁩ and #NadiaHarbeck on the nominations!

Now to vote 🗳️🗳️🗳️

ESMO Presidential Election: 2027-2028 esmo.org/about-esmo/how…

#RIGHTChoice final results: “First-line ribociclib plus ET showed a significant PFS benefit, similar response rates, and better tolerability over combination CT in patients with clinically aggressive HR+/HER2− ABC,” (premenopausal pts).
#bcsm
OncoAlert
#metastaticbreastcancer

Now in print, an important analysis asking if high disease burden, premenopausal metastatic breast cancer needs chemo, or can be treated with CDK4/6 Inhibitors.

#RIGHTChoice —Ribociclib+ET
vs chemo—now in Journal of Clinical Oncology
OncoAlert #bcsm
ascopubs.org/doi/10.1200/JC…

Obesity➡️ worse prognosis & different biology #breastcancer .
Still, BMI is only reported in 8% of 495 trials we reviewed. More research needed to study impact of BMI on treatment efficacy and toxicity🙏 !
Josephine Van Cauwenberge KarenVanBaelen OncoAlert
doi.org/10.1186/s13058…